PEX 📈 ProShares Global Listed - Overview
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US74348A5332 • Miscellaneous Sector
PEX: Listed Private Equity, Financial Instruments, Stocks
The fund invests in financial instruments that ProShare Advisors believes, in combination, should track the performance of the index. The index is designed to measure the performance of the most actively traded listed private equity companies that mainly pursue a direct private equity investment strategy. It will invest at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. It is non-diversified. ‣ Company URL: http://www.proshares.com ‣ Domicile: United States
Additional Sources for PEX ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PEX ETF Overview
| Market Cap in USD | 12m |
| Category | Miscellaneous Sector |
| TER | 0.81% |
| IPO / Inception | 2013-02-26 |
PEX ETF Ratings
| Growth 5y | 41.6% |
| Fundamental | - |
| Dividend | 80.1% |
| Rel. Strength Industry | -46.6 |
| Analysts | - |
| Fair Price Momentum | 28.48 USD |
| Fair Price DCF | - |
PEX Dividends
| Dividend Yield 12m | 14.21% |
| Yield on Cost 5y | 18.24% |
| Annual Growth 5y | 17.30% |
| Payout Consistency | 60.0% |
PEX Growth Ratios
| Growth Correlation 3m | 56.5% |
| Growth Correlation 12m | 88.4% |
| Growth Correlation 5y | 55.7% |
| CAGR 5y | 5.12% |
| CAGR/Mean DD 5y | 0.39 |
| Sharpe Ratio 12m | 0.78 |
| Alpha | -12.44 |
| Beta | 1.11 |
| Volatility | 11.47% |
| Current Volume | 7.5k |
| Average Volume 20d | 4.9k |
What is the price of PEX stocks?
As of January 15, 2025, the stock is trading at USD 27.59 with a total of 7,473 shares traded.
Over the past week, the price has changed by -2.36%, over one month by -2.22%, over three months by +0.11% and over the past year by +12.80%.
As of January 15, 2025, the stock is trading at USD 27.59 with a total of 7,473 shares traded.
Over the past week, the price has changed by -2.36%, over one month by -2.22%, over three months by +0.11% and over the past year by +12.80%.
Is ProShares Global Listed a good stock to buy?
Partly, yes. Based on ValueRay Analyses, ProShares Global Listed (BATS:PEX) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 41.55 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PEX as of January 2025 is 28.48. This means that PEX is currently overvalued and has a potential downside of 3.23%.
Partly, yes. Based on ValueRay Analyses, ProShares Global Listed (BATS:PEX) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 41.55 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PEX as of January 2025 is 28.48. This means that PEX is currently overvalued and has a potential downside of 3.23%.
Is PEX a buy, sell or hold?
ProShares Global Listed has no consensus analysts rating.
ProShares Global Listed has no consensus analysts rating.
What are the forecast for PEX stock price target?
According to ValueRays Forecast Model, PEX ProShares Global Listed will be worth about 31.8 in January 2026. The stock is currently trading at 27.59. This means that the stock has a potential upside of +15.19%.
According to ValueRays Forecast Model, PEX ProShares Global Listed will be worth about 31.8 in January 2026. The stock is currently trading at 27.59. This means that the stock has a potential upside of +15.19%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31.8 | 15.2% |